Adults pursuing weight management, energy support, or general metabolic wellness who meet clinical eligibility criteria
Approach Phase 2b trial arm Duration 24 weeks Review Point Week 12 and 24 Notes METAOD006 (OPTIONS) used 24 weeks at oral doses 0.25, 0.5, or 1 mg/day in 502 obese adults
To view more episodes, subscribe, and ask your questions, go to mikereinold.com/askmikereinold
Gabrielle Radabaugh, NP, has led Beyond Concierge Healthcare since 2022 with one belief: healthcare should feel personal
You may also request an appointment online to get started on your journey to renewed vitality today.
It is not intended for human consumption, clinical use, therapeutic applications, veterinary use, or diagnostic procedures